Abstract 9793: Temporal Trends in Utilization of Cardiovascular-Kidney-Metabolic Syndrome Directed Therapies Among Patients with HFpEF: A Contemporary Real-World Analysis of Over 1.2 Million Patients
Background: Heart failure with preserved ejection fraction (HFpEF) represents a central manifestation of cardiovascular-kidney-metabolic (CKM) syndrome and is associated with substantial cardiovascular and renal morbidity. Contemporary guidelines increasingly recommend CKM-directed therapies, including sodium-glucos...